Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.
Emma Olive BillingtonW D LeslieJ P BrownJ C PriorS N MorinC S KovacsS M KaiserB C LentleT AnastassiadesT TowheedG A KlinePublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2021)
Infrequent infusions of zoledronic acid, initiated early in menopause, are expected to reduce long-term fracture risk and result in a substantial reduction in the proportion of women with densitometric osteoporosis after age 65.